Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer PatientsCompleted
NCT01284920Phase 1, Phase 2Updated Nov 21, 2024
Sponsor: Astellas Pharma Inc
Prostate Cancer · Prostate Neoplasms · Castration Resistant Prostate Cancer (CRPC)
Japan
A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based ChemotherapyCompleted
NCT02124668Phase 2Updated Nov 21, 2024
Sponsor: Astellas Pharma Europe B.V.
Castration-Resistant Prostate Cancer · Prostate Cancer
Georgia, Russia
A Study to Learn Safety and Blood Levels of PF-07817883 in Healthy PeopleCompleted
NCT05580003Phase 1Updated Nov 21, 2024
Sponsor: Pfizer
Healthy
United States, Belgium
A Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for NephrectomyCompleted
NCT01693822Phase 2Updated Nov 21, 2024
Sponsor: Institute of Cancer Research, United Kingdom
Clear-cell Metastatic Renal Cell Carcinoma
United Kingdom
A Study to Learn About the Study Medicine (Maplirpacept) in People With Advanced Non-Hodgkin Lymphoma or Multiple Myeloma in ChinaCompleted
NCT05896774Phase 1Updated Nov 20, 2024
Sponsor: Pfizer
Non-Hodgkin Lymphoma · Multiple Myeloma
China
A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate CancerCompleted
NCT04094519Phase 1Updated Nov 20, 2024
Sponsor: Astellas Pharma Global Development, Inc.
Prostate Cancer
Moldova
A STUDY TO LEARN HOW THE STUDY MEDICINE CALLED PF-07293893 AFFECTS MUSCLE BIOMARKERS OF HEALTHY ADULTSCompleted
NCT06413693Phase 1Updated Nov 20, 2024
Sponsor: Pfizer
Healthy Participants
United States
Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)Completed
NCT02380274N/AUpdated Nov 20, 2024
Sponsor: Astellas Pharma Global Development, Inc.
Prostate Cancer · Castration-resistant Prostate Cancer · Metastatic Prostate Cancer
United States
Expanded Access Protocol for Adults and Pediatric Patients With Sickle Cell Disease Who Have No Alternative Treatment OptionsNo Longer Available
NCT04724421N/AUpdated Nov 20, 2024
Sponsor: Pfizer
Sickle Cell Disease
United States, Brazil
Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian CancerTerminated
NCT05261490Phase 1, Phase 2Updated Nov 19, 2024
Sponsor: Pfizer
Ovarian Cancer · Ovarian Neoplasms · Ovarian Carcinoma · Fallopian Tube Cancer
United States
Open Label Extension Study of Brentuximab Vedotin in Early dcSScRecruiting
NCT05149768Phase 2Updated Nov 18, 2024
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Diffuse Cutaneous Systemic Sclerosis
Canada
A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid TumorsActive Not Recruiting
NCT05262400Phase 1, Phase 2Updated Nov 18, 2024
Sponsor: Pfizer
Breast Cancer · Solid Tumors
United States, Argentina, Brazil, Bulgaria, China +4 more
A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult ParticipantsTerminated
NCT05788328Phase 1Updated Nov 15, 2024
Sponsor: Pfizer
Healthy
United States
A Study Evaluating Relative Bioavailability of an Oral Suspension of Abrocitinib and Effect of an Acid Reducing Agent on the Bioavailability of Abrocitinib and Assessing the Taste of Abrocitinib Oral Formulations.Completed
NCT04903093Phase 1Updated Nov 14, 2024
Sponsor: Pfizer
Healthy Volunteers
United States
A First-in-human Study of Multiple Doses of Topically Administered PF-07295324 and PF-07259955Completed
NCT05206604Phase 1Updated Nov 14, 2024
Sponsor: Pfizer
Healthy
United States
A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)Completed
NCT01740427Phase 3Updated Nov 14, 2024
Sponsor: Pfizer
Breast Neoplasms
United States, Australia, Belgium, Canada, Czechia +13 more
A Study to Learn About the Tastes of Different Suspensions With the Study Medicine (PF-07923568) in Healthy Adult Participants.Completed
NCT06003829Phase 1Updated Nov 13, 2024
Sponsor: Pfizer
Healthy
Belgium
A Study to Learn About the Vepdegestrant (ARV-471, PF-07850327) in People With ER+/HER2- Locally Advanced or Metastatic Breast Cancer (BC)Active Not Recruiting
NCT05463952Phase 1Updated Nov 13, 2024
Sponsor: Pfizer
Breast Neoplasms
Japan
Long Term Safety Observation of Crizotinib in Chinese NSCLC PopulationTerminated
NCT03672643Phase 4Updated Nov 8, 2024
Sponsor: Pfizer
ALK or ROS1-positive NSCLC
China
Bioavailability of Bosutinib Administered as Capsule Contents Mixed With Applesauce or Yogurt Relative to Intact Capsules Under Fed ConditionCompleted
NCT04916769Phase 1Updated Nov 7, 2024
Sponsor: Pfizer
Healthy Participants
Belgium
A Study to Learn About the Study Medicine (Called Maplirpacept (PF-07901801)) in Japanese With Hematologic MalignanciesCompleted
NCT05567887Phase 1Updated Nov 6, 2024
Sponsor: Pfizer
Lymphoma · Multiple Myeloma
Japan
A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In CombinationTerminated
NCT06448364Phase 1Updated Nov 6, 2024
Sponsor: Pfizer
Advanced or Metastatic Solid Tumors · Non-Small Cell Lung Cancer · Colorectal Cancer · Urothelial Cancer
United States, Puerto Rico
A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Infants and Young ChildrenCompleted
NCT03574389Phase 3Updated Nov 5, 2024
Sponsor: Pfizer
Pneumococcal Infections · Pneumococcal Conjugate Vaccine
China
A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With ObesityCompleted
NCT04707313Phase 2Updated Nov 5, 2024
Sponsor: Pfizer
Obesity
United States, Canada, Japan, Taiwan
A Clinical Trial of the Study Medicine (PF-07081532) in People With Diabetes and Kidney DysfunctionTerminated
NCT05510245Phase 1Updated Nov 5, 2024
Sponsor: Pfizer
Type 2 Diabetes · Renal Impairment
United States

Previous page Next page